Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
New England Journal of MedicinePublished 15 November 2001
Eric A. Rose, Annetine C. Gelijns, Alan J. Moskowitz, Daniel F. Heitjan, Lynne Warner Stevenson, Walter P. Dembitsky
Citations3,929
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The use of a left ventricular assist device in patients with advanced heart failure resulted in a clinically meaningful survival benefit and an improved quality of life.
Abstract
The use of a left ventricular assist device in patients with advanced heart failure resulted in a clinically meaningful survival benefit and an improved quality of life. A left ventricular assist device is an acceptable alternative therapy in selected patients who are not candidates for cardiac transplantation.
Keywords
MedicineEngineering
New England Journal of MedicineEffect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure
8,006 Citations1991The SOLVD Investigators*
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.
Medical CareThe MOS 36-Item Short-Form Health Survey (SF-36)
6,672 Citations1993Colleen A. McHorney, WARE JOHNE +1 more
Cross-sectional data from the Medical Outcomes Study were analyzed to test the validity of the MOS 36-Item Short-Form Health Survey (SF-36) scales as measures of physical and mental health constructs and found the social functioning, vitality, and general health perceptions scales had the most complex interpretation.
New England Journal of MedicineEffect of Carvedilol on Survival in Severe Chronic Heart Failure
3,074 Citations2001Milton Packer, Andrew J.S. Coats +12 more
New England Journal of MedicineEffect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
2,212 Citations1991Milton Packer, Joseph R. Carver +13 more
The findings indicate that despite its beneficial hemodynamic actions, long-term therapy with oral milrinone increases the morbidity and mortality of patients with severe chronic heart failure.
CirculationValue of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure.
1,882 Citations1991Donna Mancini, Howard J. Eisen +4 more
These data suggest that cardiac transplantation can be safely deferred in ambulatory patients with severe left ventricular dysfunction and peak exercise Vo2 of more than 14 ml/min/kg.
ACC Current Journal ReviewEffect of carvedilol on survival in severe chronic heart failure
1,665 Citations2001Milton Packer, Andrew J.S. Coats +1 more
The previously reported benefits of carvedilol with regard to morbidity and mortality in patients with mild-to-moderate heart failure were also apparent in the patients with severe heart failure who were evaluated in this trial.
Journal of Thoracic and Cardiovascular SurgeryGuidelines for reporting morbidity and mortality after cardiac valvular operations
1,006 Citations1996L. Henry Edmunds, Richard E. Clark +4 more
American Heart JournalAssessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
988 Citations1992Thomas S. Rector, Jay N. Cohn
To determine the reliability and validity of a patient outcome questionnaire for chronic heart failure, a randomized, double-blind, placebo-controlled, 3-month trial of pimobendan, an investigational medication with inotropic and vasodilator activities, was performed.
American Heart JournalA randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
659 Citations1997Robert M. Califf, Kirkwood F. Adams +12 more
Chronic intravenous epoprostenol therapy is not associated with improvement in distance walked, quality of life, or morbid events and is associated with an increased risk of death.
The Annals of Thoracic SurgeryGuidelines for Reporting Morbidity and Mortality After Cardiac Valvular Operations
536 Citations1996L H Edmunds, R E Clark +4 more
The Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity "revisited" the guidelines to update and clarify definitions within the guidelines and to consider recommendations made by others.
New England Journal of MedicineImplantable Left Ventricular Assist Devices
489 Citations1998Daniel J. Goldstein, Mehmet C. Öz +1 more
Congestive heart failure affects about 1 percent of adults in the United States and is a contributing factor in over 250,000 deaths annually, more than that from breast cancer and the acquired immunodeficiency syndrome combined.
The Journal of Heart and Lung TransplantationThe Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Report—2000
459 Citations2000Jeffrey D. Hosenpud, Leah E. Bennett +3 more
The Registry of the International Society for Heart and Lung Transplantation has grown substantially during the past 5 years, from a little more than 43,000 registered procedures at the end of 1994 to almost 70,000registered procedures by theend of 1999 (see Table I).
The Annals of Thoracic SurgeryMulticenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device
406 Citations1992O.H. Frazier, Eric A. Rose +5 more
The HeartMate 1000 IP LVAD has been shown to be effective in supporting end-stage cardiomyopathy patients to transplantation and thromboembolism, previously regarded as a serious complication with such devices, has not been a problem with this device.
The Annals of Thoracic SurgeryThe REMATCH trial: rationale, design, and end points
364 Citations1999Eric A. Rose, Alan J. Moskowitz +15 more
The rationale for conducting REMATCH is discussed, the obstacles to designing this and other randomized surgical trials, the lessons learned in conducting the multicenter pilot study, and the features of the REMATCH study design are considered.
Journal of Cardiac FailureUse of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death
241 Citations1995Thomas S. Rector, Linda K. Tschumperlin +6 more
The data suggest that many patients with heart failure would accept some risk of drug-induced death for improved quality of life, and a 5-point improvement in the Living With Heart Failure score may be clinically significant depending on costs and adverse effects.
The Annals of Thoracic SurgeryImplantable electrical left ventricular assist systems: Bridge to transplantation and future
215 Citations1989Peer M. Portner, Philip E. Oyer +9 more
JAMASurvival After AIDS Diagnosis in Adolescents and Adults During theTreatment Era, United States, 1984-1997
183 Citations2001Lisa M. Lee, J M Karon +3 more
While AIDS incidence is declining, improved survival times present a growing public health challenge as the number of persons living with chronic human immunodeficiency virus disease/AIDS increases.
Journal of Thoracic and Cardiovascular SurgeryActivation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices
159 Citations1996Talia B. Spanier, Mehmet C. Öz +6 more
Patients supported with a left ventricular assist device, while successfully sustained without systemic anticoagulation, nevertheless have evidence of activation of coagulation and these phenomena appear to be related to the presence of the device rather than to the underlying cardiac abnormalities.
The Annals of Thoracic SurgeryClinical experience with 111 thoratec ventricular assist devices
149 Citations1999Lawrence R. McBride, Keith S. Naunheim +3 more
Despite advances, VAD support remains associated with significant morbidity and operative mortality in patients with the Thoratec VAD.
PubMedCombined Registry for the Clinical Use of Mechanical Ventricular Assist Pumps and the Total Artificial Heart in Conjunction with Heart Transplantation: Fifth Official Report--1990.
146 Citations1992Mehta Sm, Aufiero Tx +2 more
These data show the continued success with these devices for bridging critically ill patients to transplantation and supports the ongoing development of devices implanted for long-term use, which might replace orthotopic transplantation for those patients currently deemed marginal candidates.
The Annals of Thoracic SurgeryLow thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices
136 Citations1996James P. Slater, Eric A. Rose +5 more
The thromboembolic complication rate associated with this LVAD is acceptably low despite the minimal anticoagulation employed in this series, allowing consideration of long-term device use for the treatment of heart failure.
Quality of Life ResearchPhysical functioning and mental health in patients with chronic medical conditions
134 Citations1999Michael A. Singer, Wilma M. Hopman +1 more
Results support the hypothesis that physical functioning declines with advancing age and with the development of Chronic disease, but mental health remains remarkably stable regardless of chronic disease and/or advancing age.
Journal of Thoracic and Cardiovascular SurgeryEight years' experience with bridging to cardiac transplantation
130 Citations1994D. Glenn Pennington, Lawrence R. McBride +3 more
Data demonstrate the short- and long-term efficacy of bridging to transplantation with circulatory support devices and ensure that donor organs are not being "wasted" on the sickest patients.
The Annals of Thoracic SurgeryQuality of Life With an Implanted Left Ventricular Assist Device
95 Citations1997Alan J. Moskowitz, Alan Weinberg +2 more
The results portend an acceptable quality of life for long-term use of LVADs for patients with end-stage heart failure and contribute to the growing body of evidence supporting a clinical trial to test this new use.
Journal of Thoracic and Cardiovascular SurgerySingle-center experience with the thoratec ventricular assist device
93 Citations2000Reiner Körfer, Aly El‐Banayosy +8 more
The Thoratec ventricular assist device has proved to be a reliable device for bridge to transplantation and postcardiotomy support and further studies are required on patient selection and on patient and device management to reduce the incidence of complications.
The Annals of Thoracic SurgeryOutpatient Left Ventricular Assist Device Support: A Destination Rather Than a Bridge
85 Citations1996Katharine A. Catanese, Daniel J. Goldstein +8 more
Hospital discharge of patients supported with left ventricular assist devices has allowed long-term evaluation of this technology, and the findings should prompt study of their use as a long- term alternative treatment to medical management for congestive heart failure.
The American Journal of CardiologyEffects of enalapril on long-term mortality in severe congestive heart failure
75 Citations1992John Kjekshus, Karl Swedberg +1 more
Life-table analysis suggests a marked carry-over effect of treatment in the group with enalapril that lasted for up to 15 months before mortality rates became comparable in the 2 treatment groups, which strongly suggests that enAlapril confers structural protection to the failing myocardium.
ASAIO JournalGastrointestinal Consequences of Left Ventricular Assist Device Placement
27 Citations1996Nabeel G. El-Amir, Michael Gardocki +6 more
GI function in 27 left ventricular assist device recipients was evaluated using interviews, GI contrast studies, endoscopy, and 99mTc sulfur colloid studies of esophageal transit and gastric emptying; gastric function subjectively improved in all.
ASAIO JournalGastrointestinal Consequences of Left Ventricular Assist Device Placement
9 Citations1996Nabeel G. El-Amir, Michael Gardocki +6 more